Our diverse portfolio of more than 40 spinoff companies showcases our mission to make the latest scientific discoveries and inventions available to patients around the world. A dedicated team of business experts supports our ventures throughout their life cycle, from formation, management and governance to funding and potential acquisition. Startup companies can access our state-of-the-art technology Incubator, as well as the Cleveland Clinic and Lerner Research Institute’s vast resources for research and testing.
Our portfolio includes a wide range of venture technology companies, including medical devices, pharmaceuticals, diagnostics and digital health at a range of development stages.
People faced with mantle cell lymphoma (MCL), an aggressive B-cell non-Hodgkin lymphoma, needed better treatment options with fewer side effects. Cancer researchers from Cleveland Clinic went to work. Abcon Therapeutics® was born from their work on a new antibody therapy that targets MCL tumor cells while sparing healthy cells. In 2022, Abcon received its first Small Business Technology Transfer Grant from the National Institutes of Health (NIH).
FDA-cleared endovascular navigation technology makes procedures safer, faster and more precise. A GPS-like tracking system for medical procedures reduces radiation exposure, allows intraoperative 3D visualization and provides real-time guidance of catheters and guidewires.
The launch of a member-based network built on blockchain technology creates greater transparency, security and efficiency for data-sharing between healthcare providers, payers, employers and consumers.
Learn More About Our Companies
Contact us to learn more about investing with Cleveland Clinic Innovations.